The TREADON (TReatments of Exercise AnD Orthotic devices for plaNtar heel pain) Pilot and Feasibility Trial

Keele University0 sites82 target enrollmentStarted: July 5, 2016Last updated: March 14, 2022

Trial Snapshot

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33795024/ (added 04/03/2022)

•1. Adults aged = 18 years
•2. Self-reported localised pain under the heel which is aggravated by weight bearing activities, worst when first standing or after a period of rest, especially on getting out of bed in the morning, or following periods of prolonged sitting
•3. Symptom duration of episode of at least 4 weeks with a minimum pain score of 2 on a Numerical Rating Scale (NRS 0-10)
•4. Owns or has access to a mobile phone that receives text messages or a landline telephone
•5. Able and willing to participate and provide written informed consent

•1. Inflammatory arthritis (e.g. rheumatoid arthritis, ankylosing spondylitis, reactive arthritis, systemic lupus erythematosus, gout, psoriatic arthritis), fibromyalgia
•2. Serious pathologies or serious suspected pathologies (e.g. malignancy, trauma, infection)
•3. Current treatment for plantar heel pain or treatment in the last 3 months by a physiotherapist or podiatrist
•4. Previous surgery or on waiting list for surgery on the affected foot
•5. Corticosteroid injection into the affected foot in last 3 months
•6. Unwilling or unable to participate with the interventions or unable to attend clinics for treatment
•7. Unable (even with telephone support) to complete follow-up questionnaires written in English or unable to receive text messages or phone calls
•8. Known skin allergies to common orthotic device materials (e.g. adhesives, latex, sock dyes, certain shoe types)

Sponsor